Background
==========

Spontaneous tropism changes (from R5 to non-R5 or vice-versa) were observed in approximately 10% of patients between screening and study baseline in the maraviroc (MVC) clinical trials. Little is known of the biology of these apparent short-term tropism fluctuations.

Methods
=======

Population-based and \"deep\" V3-loop sequencing were performed in 53 MVC recipients in the MERIT, MOTIVATE and A4001029 studies who spontaneously changed tropism readout by the original Trofile assay between screening and baseline (\~4-8 weeks) and 72 randomly sampled patients who did not change. Tropism was inferred by \"geno2pheno\" with previously defined cutoffs: 2% X4 prevalence with a 3.5% false-positive rate (fpr) for \"deep\" sequencing; 5.75% fpr for population-based sequencing.

Results
=======

Patients changing Trofile readout from R5 to non-R5 had significantly higher screening non-R5 prevalence by \"deep\" sequencing than those who remained R5, and this increased slightly by the baseline timepoint (Table [1](#T1){ref-type="table"}). Similarly, patients who changed tropism from non-R5 to R5 in the A4001029 trial had a lower percentage of non-R5 viruses at screening and baseline. Although there was no difference in total viral load, absolute CXCR4-using plasma virus load was higher in those who changed tropism at screening (2.7 vs. 0 log~10~ copies/mL, p=0.02 in MERIT; 3.1 vs. 0 log~10~ copies/mL, p\<0.0001 in MOTIVATE) and baseline (3.0 vs. 0 log~10~ copies/mL, p=0.04 in MERIT; 3.8 vs. 0 log~10~ copies/mL, p\<0.0001 in MOTIVATE). Non-R5 was reported at screening in 26% and 49% of patients who changed phenotype to non-R5 by population and deep-sequencing, respectively.

             \# Genotyped             Screening X4% \[IQR\]                               Baseline X4% \[IQR\]                      
  ---------- -------------- --------- ----------------------- ------------------ -------- ---------------------- ------------------ ----------
             No Change      Changed   No Change               Changed            p        No Change              Changed            p
                                                                                                                                    
  MERIT      25             13        0 \[0-0\]               1.9 \[0-3.3\]      0.01     0 \[0-0.1\]            7 \[0-16.3\]       0.04
                                                                                                                                    
  MOTIVATE   25             32        0 \[0-0.1\]             2.4 \[0.1-21.3\]   0.0001   0 \[0-0.1\]            9.1 \[0.4-32.7\]   \<0.0001
                                                                                                                                    
  A4001029   22             8         5.0 \[0.2-91.5\]        1.8 \[0.4-30.6\]   0.5      4.3 \[0-76.6\]         0.4 \[0-47.5\]     0.3

Conclusions
===========

In most cases, the prevalence of non-CCR5 usage inferred from \"deep\" sequencing was stable over the short term between screening and baseline. Where apparent phenotypic tropism changes from R5 to non-R5 occurred, non-R5 virus was generally detectable at the screening timepoint by genotype, coupled with relatively small increases in non-R5 virus by baseline. Small variations in CXCR4-using HIV populations around the phenotypic assay detection limit, rather than coreceptor switch, contributed to apparent tropism switching from R5 to non-R5.
